AdvisorShares Psychedelics ETFAdvisorShares Psychedelics ETFAdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF

No trades
See on Supercharts

AdvisorShares Psychedelics ETF holdings


As of August 6, 2025
Symbol
Weight %
Shares
Market value
A
ATAIATAI Life Sciences N.V.
13.38%
‪‪418.35 K‬‬
‪‪1.75 M‬‬USD
M
MNMDMind Medicine (MindMed), Inc.
8.88%
‪‪117.63 K‬‬
‪‪1.16 M‬‬USD
Q
QNTMQuantum Biopharma Ltd. Subordinate Voting Shares Class B
7.93%
‪‪39.71 K‬‬
‪‪1.04 M‬‬USD
C
CMPSCOMPASS Pathways Plc Sponsored ADR
6.88%
‪‪206.66 K‬‬
‪‪901.06 K‬‬USD
C
CYBNCybin, Inc.
6.50%
‪‪114.18 K‬‬
‪‪851.80 K‬‬USD
A
ALKSAlkermes Public Limited Company
5.67%
‪‪27.99 K‬‬
‪‪743.11 K‬‬USD
S
STIMNeuronetics, Inc.
5.48%
‪‪169.09 K‬‬
‪‪717.81 K‬‬USD
N
NRXPNRX Pharmaceuticals, Inc.
5.31%
‪‪283.15 K‬‬
‪‪695.12 K‬‬USD
V
VTGNVistagen Therapeutics, Inc.
4.94%
‪‪218.01 K‬‬
‪‪647.48 K‬‬USD
N
NBIXNeurocrine Biosciences, Inc.
4.91%
‪‪5.01 K‬‬
‪‪643.05 K‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.